Double benefit claims for antimicrobial and antioxidative probiotic

Microbial Ecology in Health and Disease

Volumn 20, Issue 4, 2008, Pages 184-188

  Mikelsaar, Marika ^a   Hütt, Pirje ^a   Kullisaar, Tiiu ^a   Zilmer, Kersti ^a   Zilmer, Mihkel ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Antioxidative activity; Bifidobacteria; Helicobacter pylori; Lactobacilli; Oxidative stress; Probiotic; Synbiotic

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; MALTODEXTRIN; PROBIOTIC AGENT; RAFTILOSE P95; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ANTIMICROBIAL THERAPY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM; BIFIDOBACTERIUM LONGUM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFECATION; DOUBLE BLIND PROCEDURE; FEMALE; FLATULENCE; HELICOBACTER PYLORI; HUMAN; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PARACASEI; MALE; NONHUMAN; NORMAL HUMAN; OXIDATIVE STRESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

BIFIDOBACTERIUM LONGUM; HELICOBACTER PYLORI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PARACASEI;

EID: 57649114615     PISSN: 0891060X     EISSN: 16512235     Source Type: Journal    
DOI: 10.1080/08910600802408178     Document Type: Article

References (21)

1. Marco ML, Pavan S, Kleerebezem M. Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol. 2006;17:204-10.
2. Aggett PJ, Antoine JM, Asp NG, Bellisle F, Contor L, Cummings JH, et al. PASSCLAIM: consensus on criteria. Eur J Nutr. 2005;44(Suppl 1):5-30.
3. Mercenier A, Lenoir-Wijnkoop I, Sanders ME. Physiological and functional properties of probiotics. Bull Int Dairy Fed. 2008;429:2-6.
4. Kaplan M, Yavuz SS, Cinar B, Koksal V, Kut MS, Yapici F, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis. 2006;10:116-23.
5. Sawayama Y, Ariyama I, Hamada M, Otaguro S, Machi T, Taira Y, et al. Association between chronic Helicobacter pylori infection and acute ischemic stroke: Fukuoka Harasanshin Atherosclerosis Trial (FHAT). Atherosclerosis. 2005;178:303-9.
6. Schumacher A, Seljeflot I, Lerkerod AB, Sommervoll L, Otterstad JE, Arnesen H. Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease. Atherosclerosis. 2002;164:153-60.
7. Tursi A, Brandimarte G, Giorgetti GM, Modeo ME. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med Sci Monit. 2004;10:CR662-6.
8. Kullisaar T, Zilmer M, Mikelsaar M, Vihalemm T, Annuk H, Kairane C, et al. Two antioxidative lactobacilli strains as promising probiotics. Int J Food Microbiol. 2002;72:215-24.
9. Hütt P, Shchepetova J, Lõivukene K, Kullisaar T, Mikelsaar M. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J Appl Microbiol. 2006;100:1324-32.
10. Andreson H Maaroos HI Mikelsaar M Reliability of non-invasive Helicobacter pylori antigen test ImmunoCard STAT! HpSA in peptic ulcer patients after eradicative treatment. Helicobacter 2003;8:490 (abstract).
11. Krogfelt KA, Lehours P, Mégraud F. Diagnosis of Helicobacter pylori infection. Helicobacter. 2005;10(Suppl 1):5-13.
12. Songisepp E, Kals J, Kullisaar T, Mändar R, Hütt P, Zilmer M, et al. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutr J. 2005;4:22.
13. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity for monitoring the antioxidant status in premature neonates. Clin Sci (Lond). 1993;84:407-12.
14. Ahotupa M, Marniemi J, Lehtimaki T, Talvinen K, Raitakari OT, Vasankari T, et al. Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation. Clin Biochem. 1998;31:257-61.
15. Kullisaar T, Songisepp E, Mikelsaar M, Zilmer K, Vihalemm T, Zilmer M. Antioxidative probiotic fermented goats milk decreases oxidative stress-mediated atherogenicity in human subjects. Br J Nutr. 2003;90:449-56.
16. Saulnier D, Hutt P, Mikelsaar M, Bosscher D, Gibson G, Kolida S. Effects of a synbiotic on biomarkers of oxidative stress and faecal microbiota in healthy adults: results of a cross-over double-blind placebo-controlled trial. Proc Nut Soc. 2007;66:101A.
17. Hütt P Lõivukene K Utt M Antagonistic activity of probiotic Lactobacillus fermentum ME-3 against H. pylori strains. In: Abstracts: 6th International Workshop on Pathogenesis and host response in Helicobacter Infections, Helsingör, Denmark, 23-26 June, 2004.
18. Brenner H, Berg G, Frohlich M, Boeing H, Koenig W. Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults: results from a large population-based study. Atherosclerosis. 1999;147:399-403.
19. Pignatelli B, Bancel B, Plummer M, Toyokuni S, Patricot LM, Ohshima H. Helicobacter pylori eradication attenuates oxidative stress in human gastric mucosa. Am J Gastroenterol. 2001;96:1758-66.
20. Hütt P, Unt E, Shchepetova J, Smidt I, Kullisaar T, et al. H. pylori colonization is associated with general oxidative stress-related and inflammatory markers. Helicobacter 2008;13:395 (abstract).
21. Packer L, Cadenas E. Oxidants and antioxidants revisited. New concepts of oxidative stress. Free Radic Res. 2007;41:951-2.